Amendment and Mail Process Complete

BRINTELLIX

H. Lundbeck A/S

Amendment and Mail Process Complete

Trademark Snap Shot Amendment & Mail Processing Stylesheet
(Table presents the data on Amendment & Mail Processing Complete)

OVERVIEW

SERIAL NUMBER 88844656 FILING DATE 03/23/2020
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY TM ATTORNEY NOT ASSIGNED L.O. ASSIGNED NONE

PUB INFORMATION

RUN DATE 05/13/2020
PUB DATE N/A
STATUS 630-NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
STATUS DATE 03/26/2020
LITERAL MARK ELEMENT BRINTELLIX

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) NO 1 (b) NO 1 (b) NO
44D NO 44D NO 44D NO
44E YES 44E YES 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT BRINTELLIX
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME H. Lundbeck A/S
ADDRESS Ottiliavej 9
Valby, 2500
ENTITY 99-aktieselskab (a/s)
CITIZENSHIP Denmark

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Vaccines, pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, pharmaceutical preparations and substances acting on the central nervous system, central nervous system stimulants, pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases, pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, dyskinesia, poor or absent motor functions, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, headache, migraine, pain, alcoholism and chemical dependency, diagnostic agents, reagents, preparations and substances for medical purposes

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO


FOREIGN INFORMATION
PRIORITY CLAIMED N/A
APPLICATION NO. N/A
APPLICATION FILING DATE N/A
FOREIGN REG NO. VR201102843
FOREIGN REG DATE 11/17/2011
FOREIGN RNWL NUM N/A
DATE OF FOREIGN RNWL N/A
FOREIGN EXPIRATION 11/17/2021
FOREIGN RNWL EXPIRATION N/A

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
05/12/2020 AMPX O APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED 006
05/12/2020 ALIE A ASSIGNED TO LIE 005
05/04/2020 ALIE A ASSIGNED TO LIE 004
04/30/2020 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED 003
04/01/2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
03/26/2020 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Claudia A. Smith
CORRESPONDENCE ADDRESS Claudia A. Smith
WHITE & CASE LLP
TRADEMARK DEPARTMENT
1221 AVENUE OF THE AMERICAS
NEW YORK NY 10020
DOMESTIC REPRESENTATIVE Claudia A. Smith

Amendment and Mail Process Complete [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed